ACR: Albumin:creatinine ratio; CVD: Cardiovascular disease ... Para-aminohippurate (marker of renal plasma flow). Reproduced with kind permission from Springer Science and Business Media [9].
as individuals with CKD are at a significantly higher risk of developing cardiovascular diseases (CVD). Recent research has focused on understanding the underlying mechanisms connecting CKD and ...
Here, we review current knowledge regarding the genetic contributions to renal hypoplasia with particular emphasis on the mechanisms that control nephron endowment in humans and mice. Much of the ...
Therefore, more direct and larger clinical trials (involving a larger proportion of CVD/CKD patients without diabetes) are needed to assess this drug. By exploring the cardiorenal protective effects ...
Role of altered intestinal microbiota in the pathogenesis of systemic inflammation & cardiovascular disease in chronic kidney disease patients The firmicutes/bacteroidetes ratio is an important ...
Background: Chronic kidney disease (CKD) has emerged as an independent risk factor for cerebral microhemorrhages (CMH). We examined molecular mechanisms of CMH formation in mouse models of CKD and ...
New research funding will investigate the early stages of heart disease associated ... Foundation to understand the mechanisms driving the early stages of CKD-associated cardiomyopathy.
The mechanisms responsible for these associations are currently unclear ... There was a significant elevation in malondialdehyde levels (a biomarker of oxidative stress) in patients with CKD with ...
New research funding will investigate the early stages of heart disease associated with chronic kidney disease led by the University of Birmingham. Dr Davor Pavlovic will lead an international ...